Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access

Program Description

Many patients with diabetes do not meet glycemic targets, which can increase risk for complications that increase healthcare resource utilization and decrease patient quality of life. Research has indicated that patients whose diabetes is not adequately controlled are often adversely affected by health disparities and social determinants of health that prevent consistent utilization of healthcare treatment. The use of continuous glucose monitoring (CGM) devices are emerging as new, cost-effective standard of care options to be incorporated into diabetes management plans to enhance patient monitoring and, subsequently, patient outcomes. This supplement will examine real-world evidence and cost-savings models utilizing CGM to assist managed care pharmacists in developing strategies to minimize costs and access barriers associated with CGM for patients with diabetes.

Target audience: Managed care pharmacists, health system pharmacists, and retail pharmacists

Type of activity: Application
Release date: July 11, 2022
Expiration date: July 11, 2023

Time to complete activity: 3.0 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the guideline recommendations and recent data on the clinical benefits and optimal use of continuous glucose monitoring (CGM) for the management of diabetes.
• Explore the social determinants of health that negatively affect patients with diabetes and strategies to promote health equity.
• Investigate the value of CGM in optimizing the management of diabetes and opportunities to promote access to appropriate patients.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hour (0.30 CEU) under the ACPE universal activity number 0290-0000-22-285-H01-P. The activity is available for CE credit through July 11, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Carrie McAdam-Marx, PhD, RPh, has no relevant financial relationships with commercial interests to disclose.

Jeff Unger, MD, FAAFP, FACE, has the following relevant financial relationships with commercial interests to disclose:

Consultant: Abbott Diabetes Care Inc, Dexcom

Other (Honoraria): Abbott Diabetes Care Inc

Other (Lecture Fees): Novo Nordisk

Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP, has the following relevant financial relationships with commercial interests to disclose:

Speaker’s Bureau: Novo Nordisk, Xeris, Amarin, Abbott Diabetes Care Inc, Lilly

Stock: Novo Nordisk, Abbott Diabetes Care Inc, Lilly

Medical Writing and Editorial Support

Brittany Hoffmann-Eubanks, PharmD, MBA; Angel A. Rodriguez, PharmD; Jeannette Y. Wick, MBA, RPh, FASCP, FASB; and Lori A. Uildriks, PharmD, BCPS, BCGP, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms